Advanced Melanoma: RO7276389 and Cobimetinib Study

We are evaluating a new treatment for patients with advanced solid tumors or melanoma that have a specific genetic mutation. This study looks at the safety and early effects of the treatment alone and in combination with another drug.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
UZ Brussel
Medical oncology
Ganshoren, Belgium
UZ Leuven
General medical oncology
Heverlee, Belgium
Antwerp University Hospital
Medical oncology
Wilrijk, Belgium

Sponsor: F. Hoffmann-La Roche AG
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.